Himalaya Liv 52- DS 90 Tablets

Protects the liver
Liv.52 DS Tablet is a hepatospecific formulation that helps protect the liver and enhance liver functions. It supports liver health and metabolic functions, and helps reduce the build-up of fat in the liver caused by dietary and lifestyle challenges. Additionally, it protects the liver from the harmful effects of toxic substances and serves as an adjuvant during antitubercular therapy.

Ingredients

Additional information
Dosage:
1–2 tablets twice daily or as directed by the physician.

Indications
- Symptomatic improvement and supportive treatment of early and mild-to-moderate:
-->  fatty liver disease (NAFLD)
--> Drug-induced liver injury (DILI)
- As an adjuvant to hepatotoxic drugs like antitubercular drugs, statins, and antiretrovirals.

Adverse Effects:
Liv.52 DS Tablet is not known to have any significant adverse reaction or serious adverse event if taken as per the prescribed dosage.

Disclaimer
Note: The information on this page is not intended to be a substitute for professional medical advice. Do not use this information to diagnose or treat your problem without consulting your doctor.
Do not self-medicate. Always consult your doctor before taking any medicines.

Fact Check
Liv.52 was launched in 1955, and physicians worldwide recommend Liv.52 (tablet, syrup, and drops forms), for various hepatic disorders. Liv.52 is an extensively researched product of Himalaya Wellness Company. The potential hepatoprotective effect of Liv.52 has been established through numerous clinical studies, including randomized double blind, placebo controlled, open label studies, as well as independent investigator initiated clinical studies across many countries. The product has numerous research articles published in national and international scientific journals. Overall, the results derived from these research articles suggest that Liv.52 is beneficial for supportive treatment in improving the symptoms, hepatic parameters, and quality of life in a wide variety of liver diseases like drug-induced hepatotoxicity, hepatitis,  liver disease, and  fatty liver disease.

Each herbal ingredient of Liv.52 is analyzed as per the standards set by Pharmacopoeia (IP, BP, EP, and USP)*. A battery of non-clinical toxicological studies (acute, subacute, chronic, genotoxicity, developmental, and reproductive toxicity studies) have further reinforced the safety of Liv.52, with a wide margin of safety. Himalaya Wellness Company's advanced Research and Development (R&D) Center is certified for Good Laboratory Practices (GLP) for following international Organization for Economic Co-operation and Development (OECD) guidelines.

We ensure consistent quality in every batch (as per WHO standards for herbal medicines). Himalaya's manufacturing facility is GMP certified and audited at regular intervals by the Ministry of Health (MOH) and regulatory bodies of several countries.

Considering some trace levels of heavy metals occurring naturally in botanical/plants/food ingredients, many regulatory bodies have defined the permissible limits for heavy metal contaminants in herbal medicines after considering the geographical aspects of such contaminants. In this direction, both WHO and AYUSH have defined the limits of heavy metals (lead, cadmium, arsenic, ) in herbal medicines. We, at Himalaya Wellness Company, follow these guidelines for all our medicinal products and ensure that our products comply with these regulations.

* IP: Indian Pharmacopoeia
BP: British Pharmacopoeia
EP: European Pharmacopoeia
USP: United States Pharmacopoeia